![](https://www.iaso-bioproduction.com/_img/qBGTTEEHYrJ4FzurPKwsEC0KJLM=/fit-in/1140_x_600/filters:no_upscale():strip_exif()/reboot/media/e1076a0a-7298-11eb-99f3-0242ac130004/ae715eac-ad5f-11ee-a1d0-0242ac12000a/1-1-iaso.jpg)
DIFFERENTIATING from current expression systems (animal cells, yeasts, bacteria):
►NINKARAK®: recombinant immunotoxins and fusion proteins ('recalcitrant', 'difficult-to-express' proteins)
►ALGAVAX®: thermostable subunit vaccines, alongwith vegetal adjuvants
►ALGAPHARM®: nasal, oral, pulmonary, topical delivery, innovative galenic pharmacology by controlled cellular fragmentation of microalgae
►ALGATHERAPEUTICS®: in the longer run, with the aim to manufacture other types of recombinant proteins in commercial quantities at a reduced cost.